Beranda › Kanker Payudara › Distrik Columbia
Uji klinis Kanker Payudara di Distrik Columbia
28 studi untuk Kanker Payudara mencari peserta di lokasi di Distrik Columbia.
Kota di Distrik Columbia
Teks studi resmi (Bahasa Inggris)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Georgetown University Medical Center, Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06982521Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Georgetown University Lombardi Cancer Center, Washington D.C.
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Older Breast Cancer Patients: Risk for Cognitive Decline
- Georgetown University, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 60 hingga 105 · Wanita · Diperbarui 28 Sep 2026 · NCT03451383ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- The George Washington Medical facility Associates, Washington D.C.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07007559A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07174336A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Georgetown Uni Hospital, Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05894239Identifying Patterns in the Breath of Individuals With Breast Cancer
- GW Comprehensive Breast Center, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 74 · Wanita · Diperbarui 18 Sep 2026 · NCT06512350A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06492616A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaFase 1
Usia 18 hingga 55 · Wanita · Diperbarui 9 Sep 2026 · NCT07310420Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Georgetown University, Washington D.C.
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05315700Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
- Georgetown University Medical Center, Washington D.C.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06533826Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
- Sibley Memorial Hospital, Washington D.C.
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 21 Agu 2026 · NCT06536881Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Sibley Memorial Hospital, Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06500481Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05232916E-Mindfulness Approaches for Living After Breast Cancer
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaFase 3
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Georgetown University Medical Center, Washington D.C.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- MedStar Washington Hospital Center, Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07062965De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Menerima pesertaFase 3
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT02333604Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
- Georgetown University, Washington D.C.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT04841148Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
- George Washington-Medical Faculty Associates, Washington D.C.
Menerima pesertaFase 2
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 3 Mar 2026 · NCT06806930The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
- Sibley Memorial Hospital, Washington D.C.
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 23 Feb 2026 · NCT05780814Study in Patients With Breast Cancer Leptomeningeal Metastasis
- Sibley Memorial Hospital, Washington D.C.
Menerima pesertaStudi observasional
18 Weeks · Semua jenis kelamin · Diperbarui 28 Nov 2025 · NCT06638294The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
- Georgetown University, Washington D.C.
Menerima peserta
Usia 18 hingga 74 · Wanita · Diperbarui 30 Sep 2025 · NCT06892275CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 28 Agu 2025 · NCT05130606CtDNA Based MRD Testing for NAC Monitoring in TNBC
- George Washington University, Washington D.C.
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 7 Jan 2025 · NCT06230185Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.